Budget Accord Should Increase FDA Funding, Free Up User Fees
This article was originally published in The Gray Sheet
Executive Summary
The deal, which sets total FY 2014 discretionary spending at $1.012 trillion, leaves specific appropriations up to congressional committees and frees up user fees from sequestration for two years, both positive developments for FDA’s financial health. Device groups also tout a non-binding provision to repeal the device tax.